Correspondence 0001140361-23-026700 from Solana Co (HSDT)
Solana Co
Date: May 25, 2023 · CIK: 0001610853 · Accession: 0001140361-23-026700
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-270433
Letter
Re: Helius Medical Technologies, Inc.
May 25, 2023
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F. Street, NE
Washington, D.C. 20549
Attention: Jessica Ansart
Registration Statement on Form S-3
File No. 333-270433
Acceleration Request
Requested Date: May 26, 2023
Requested Time: 4:00 P.M. Eastern Time
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Helius Medical Technologies, Inc. (the “Company”) hereby respectfully requests that the above-referenced Registration Statement on Form S-3 (File No. 333-270433) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above, or as soon as practicable thereafter, or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission. The Company hereby authorizes each of Emily Johns and Garrett Packer of Honigman LLP, counsel to the Company, to make such request on its behalf.
Please confirm the effectiveness of the Registration Statement with Emily Johns of Honigman LLP by telephone at (616) 649-1908 or Garrett Packer of Honigman LLP by telephone at (313) 465-8090.
[Signature page follows]
****
Sincerely,
Helius Medical Technologies, Inc.
Show Raw Text
CORRESP
1
filename1.htm
May 25, 2023
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F. Street, NE
Washington, D.C. 20549
Attention: Jessica Ansart
Re: Helius Medical Technologies, Inc.
Registration Statement on Form S-3
File No. 333-270433
Acceleration Request
Requested Date: May 26, 2023
Requested Time: 4:00 P.M. Eastern Time
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Helius Medical Technologies, Inc. (the “Company”) hereby respectfully requests that the
above-referenced Registration Statement on Form S-3 (File No. 333-270433) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above, or as soon as
practicable thereafter, or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission. The Company hereby authorizes each of
Emily Johns and Garrett Packer of Honigman LLP, counsel to the Company, to make such request on its behalf.
Please confirm the effectiveness of the Registration Statement with Emily Johns of Honigman LLP by telephone at (616) 649-1908 or Garrett Packer of Honigman LLP by telephone at (313) 465-8090.
[Signature page follows]
****
Sincerely,
Helius Medical Technologies, Inc.
/s/ Dane C. Andreeff
Dane C. Andreeff
President and Chief Executive Officer
cc:
Emily Johns, Honigman LLP
Garrett Packer, Honigman LLP